Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

Trial Profile

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Aug 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Hidradenitis suppurativa
  • Focus Therapeutic Use
  • Acronyms Harmony
  • Sponsors AbbVie
  • Most Recent Events

    • 15 Aug 2017 Planned number of patients changed from 350 to 200.
    • 15 Aug 2017 Planned End Date changed from 5 Jul 2019 to 31 Dec 2018.
    • 15 Aug 2017 Planned primary completion date changed from 5 Jul 2019 to 31 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top